VIVEVE MEDICAL, INC. 4
4 · VIVEVE MEDICAL, INC. · Filed Jun 21, 2016
Insider Transaction Report
Form 4
Durbin Scott
Chief Financial Officer
Transactions
- Purchase
Common Stock
2016-06-17$5.00/sh+1,500$7,500→ 6,568 total
Footnotes (2)
- [F1]The reporting person purchased these shares in connection with the closing of a public offering of the Issuer's common stock (the "Offering") at the Offering price of $5.00 per share. The shares are subject to a lock-up provision for a period of 90 days following June 14, 2016, as required under a lock-up agreement with the underwriters of the Offering.
- [F2]On April 15, 2016, the Issuer effected a 1-for-8 reverse stock split of its common stock (the "Split"), which began trading on a post-Split basis on April 18, 2016. The amount reported in Column 5 represents securities beneficially owned on a post-Split basis.